fMRI and Ghlrein in Obesity and Binge Eating Disorder

NCT ID: NCT02038712

Last Updated: 2014-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

93 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-06-30

Study Completion Date

2013-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Binge Eating Disorder (BED) may be associated with he development of obesity. However, the pathogenesis of BED is currently unclear, thus making the development of treatment and prevention strategies for BED difficult. Differences in the mechanisms regulating food intake may go some way to reveal potential mechanisms for BED.The purpose of this study is to investigate the responses of key gut-derived hormones that are associated with the regulation of food intake and functional brain activity to food cues using fMRI in BED patients and weight matched controls.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will attend the laboratory on two separate occasions following an overnight fast. Following baseline measures they will be provided wither with a 600mL (600kcal) liquid meal (Fed condition) or a volume matched amount of plain water (Fasted condition) to consume within 15 min in a randomized crossover design. Blood samples will be collected for during the subsequent 120min to measure the glucose, insulin and gut hormone responses, and subjective appetite ratings will be collected. 1500mg of acetaminophen will be added to each of the test drinks so that the appearance in the blood can be used as a proxy measure of gastric emptying. Participants will then undergo a 45min brain scan to assess the responses to visual and auditory food cues.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Binge Eating Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Binge eating disorder (BED)

Blood samples, subjective appetite ratings and fMRI scan will be collected in subjects who meet the current criteria for binge eating disorder (BED) in the fed condition and fasted condition.

Group Type EXPERIMENTAL

Fed Condition

Intervention Type DIETARY_SUPPLEMENT

Subjects will consume a 600mL 600kcal liquid test meal

Fasted condition

Intervention Type DIETARY_SUPPLEMENT

Subjects will consume 600mL plain water.

Blood samples

Intervention Type PROCEDURE

Blood samples will be collected at -15, 0, 10, 30, 60, 90, 120 min

Subjective appetite ratings

Intervention Type BEHAVIORAL

Appetite ratings will be collected at -15, 0, 10, 30, 60, 90, 120 min.

fMRI scan

Intervention Type PROCEDURE

Blood Oxygen Dependent (BOLD) signal response to pictures and words of food and non-food items will be measured using functional magnetic resonance imaging (fMRI).

Control

Blood samples, subjective appetite ratings and fMRI scan will be collected in subjects who do not meet the current criteria for BED (Controls) in the fed condition and fasted condition.

Group Type EXPERIMENTAL

Fed Condition

Intervention Type DIETARY_SUPPLEMENT

Subjects will consume a 600mL 600kcal liquid test meal

Fasted condition

Intervention Type DIETARY_SUPPLEMENT

Subjects will consume 600mL plain water.

Blood samples

Intervention Type PROCEDURE

Blood samples will be collected at -15, 0, 10, 30, 60, 90, 120 min

Subjective appetite ratings

Intervention Type BEHAVIORAL

Appetite ratings will be collected at -15, 0, 10, 30, 60, 90, 120 min.

fMRI scan

Intervention Type PROCEDURE

Blood Oxygen Dependent (BOLD) signal response to pictures and words of food and non-food items will be measured using functional magnetic resonance imaging (fMRI).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fed Condition

Subjects will consume a 600mL 600kcal liquid test meal

Intervention Type DIETARY_SUPPLEMENT

Fasted condition

Subjects will consume 600mL plain water.

Intervention Type DIETARY_SUPPLEMENT

Blood samples

Blood samples will be collected at -15, 0, 10, 30, 60, 90, 120 min

Intervention Type PROCEDURE

Subjective appetite ratings

Appetite ratings will be collected at -15, 0, 10, 30, 60, 90, 120 min.

Intervention Type BEHAVIORAL

fMRI scan

Blood Oxygen Dependent (BOLD) signal response to pictures and words of food and non-food items will be measured using functional magnetic resonance imaging (fMRI).

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Boost (Novartis Nutrition)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-65 years
* BMI 30-50 kg/m2
* Weight stable (\<5% change in body weight during past 3 months)
* Right handed

Exclusion Criteria

* Smokers
* Regular use of medications
* Current or intended participation in a weight-loss program (diet or exercise)
* Females who are pregnant or lactating
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Columbia University

OTHER

Sponsor Role collaborator

New York Obesity and Nutrition Research Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Allan Geliebter

Senior Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Allan Geliebter, PhD

Role: PRINCIPAL_INVESTIGATOR

New York Obesity Nutrition Research Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

06-164

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Binges and Neural Variability
NCT04184856 COMPLETED
Self-Control in Bulimia Nervosa
NCT04409457 COMPLETED NA
Compuls-BED-Severity
NCT05149859 RECRUITING